![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0791.jpg)
/
Matthias Guckenberger - SBRT for stage I NSCLC
49
Stereotactic ablative radiotherapy versus lobectomy for operable
stage I non-small-cell lung cancer: a pooled analysis of two
randomised trials
Chang
Lancet Oncol 2015
Grade 3
Grade 4
Grade 5
SBRT n=31
10%
0%
0%
Lobectomy n=27
44%
4%
Freedom from
local progresion
Freedom from
regional recurrence
Freedom from
Distant metastases